Celularity Inc.

Contributing Author

Recent Articles by Celularity Inc.

Dec-26	Celularity CEO Comments on Centers for Medicare & Medicaid Services' Withdrawal of Skin Substitute Local Coverage Determinations CELU GlobeNewswire
Dec-22	Celularity Announces Closing of Financing Transactions CELU GlobeNewswire
Dec-18	Celularity Reaches Binding Term Sheets on Financing Transactions to Support Its Strategic Vision CELU GlobeNewswire
Oct-30	Celularity and DefEYE, Inc. Partner to Advance Growth of Regenerative Therapies in Eye Care CELU GlobeNewswire
Oct-14	Celularity Announces Peer-Reviewed Publication of Phase 2 Clinical Trial Results Demonstrating the Safety and Efficacy of Human Placenta-Derived Cells (PDA-002) for Diabetic Foot Ulcers Complicated by Peripheral Artery Disease CELU GlobeNewswire
Sep-03	Celularity Announces Filing of Form 10-Q Quarterly Reports for the First Quarter and the Second Quarter 2025, Confirmation of Nasdaq Listing Rule 5250(c)(1) Compliance CELU GlobeNewswire
Aug-22	Celularity Receives Nasdaq Notice Regarding Form 10-Q CELU GlobeNewswire
Aug-18	Celularity Completes Major Balance Sheet Restructuring, Retires All $41.6 Million in Senior Secured Debt CELU GlobeNewswire
Jul-09	Celularity & Fountain Life Announce Partnership to Deliver Stem Cell Therapies Under New Florida Law CELU GlobeNewswire
Jul-01	Celularity Hails New Florida Law Opening Patient Access to Stem Cell Therapies CELU GlobeNewswire
Jun-10	Celularity Announces Chief Financial Officer Transition CELU GlobeNewswire
Jun-02	Celularity Announces Publication Advancing Ocular Surface Reconstruction with Tri-Layer Amniotic Membrane Technology CELU GlobeNewswire
May-30	Celularity Receives Nasdaq Notice Regarding Form 10-Q CELU GlobeNewswire
May-09	Celularity Announces Full Year 2024 Operating and Financial Results CELU GlobeNewswire

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved.